Nearly 80,000 workers in the Houston area travel at least 90 minutes each way for their jobs. Photo via Getty Images

If you’re a workday commuter in the Houston metro area, you may be among the many motorists who’ve cursed the snarled traffic on I-610/West Loop Freeway. This route routinely takes the crown as the most clogged roadway in Texas.

But imagine if you were one of the nearly 80,000 workers in the Houston area who travel at least 90 minutes each way for their jobs. That’s an even more gripe-worthy commuting scenario.

U.S. Census Bureau data gathered by Apartment List shows that as of 2022 in the Houston area, 79,645 workers were tagged as “super commuters.” These workers represent three percent of all commuters in the region.

The Houston area’s 2022 number is down slightly from the pre-pandemic year of 2019, when 82,878 workers across the region were super commuters, according to Apartment List.

Igor Popov, chief economist at Apartment List, says 3.7 million American workers spent at least 90 minutes traveling each way for their jobs in 2022. These extreme commutes are becoming more commonplace as suburban populations rise and employers pull back on remote work, he says.

Nationally, the number of super commuters jumped by 593,000 in 2022 compared with 2021, when the pandemic caused the figure to plummet by more than 1.5 million.

“Generally, super commuting is most common for transit users, workers who live on the fringes of the metropolitan area, or those who commute to separate metros entirely,” Popov says.

Super commuting is also common among high-income workers who are willing to travel longer distances for higher-wage jobs, according to Popov.

A recent study by Stanford University and travel data provider INRIX mostly aligns with the Census Bureau data cited by Apartment List.

Since the pandemic, the study says, the share of one-way commutes covering at least 40 miles has gone up in the country’s 10 largest metros, including Houston. In the Houston area, the share of one-way super commutes, which the study defines as those over 75 miles, grew 18 percent from 2019-20 to 2023-24.

Among the 10 areas examined in the study, a typical two-way super commute lasts nearly four hours and 40 minutes.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston healthtech startup raises $30M to scale surgical healing gel

fresh funding

Houston-based healthtech startup TYBR Health has raised a $30 million Series A round to scale its B3 GEL System, which helps protect tendons from scarring after surgery.

The round was led by Minneapolis-based Vensana Capital and Cleveland-based Mutual Capital Partners, with participation from Denver-based Neovate Capital Partners and existing investors, according to a news release from the company.

TYBR Health said it plans to use the funding to broaden the B3 GEL System's clinical applications, expand commercialization and conduct studies to evaluate its ability to protect tissue and improve healing outcomes.

"Surgeons are exceptionally good at the structural repair, but the biology that follows is what determines how it heals. That part of the equation has gone largely unaddressed ... There's a shift underway across surgical specialties, from focusing almost entirely on the mechanical repair to also weighing the biological conditions that repair needs to succeed," Tim Keane, co-founder and CEO of TYBR Health, said in the news release. "This financing lets us reach more surgeons and generate the clinical evidence to move that shift forward."

As part of the financing round, Greg Banker of Vensana Capital and Liz Todia Zambory of Mutual Capital Partners will join the TYBR board, alongside independent director Aaron Smith.

"TYBR Health is addressing a gap surgeons have lived with for a long time, with a product that fits the way they already work," Zambory, principal at Mutual Capital Partners, added in the release. "We're excited to co-lead this round and support the company's growth."

TYBR was founded in 2020 and originated from the TMCi’s Biodesign fellowship and participated in the TMC's Accelerator for HealthTech. Its B3 GEL System is a flowable extracellular matrix hydrogel designed to protect tendons, ligaments, muscles, and the surrounding soft tissue while they heal from orthopedic surgery. It received FDA 510(k) clearance last June and launched an Australian clinical trial in the fall.

The B3 GEL System has been used in hand, wrist, shoulder, foot and ankle, and sports medicine procedures since it launched, according to the company, and was first used in the clinical setting earlier this year by Dr. Tammam Hanna with Texas Tech University Health Sciences Center.

Houston space companies win NASA funding to build Mars exploration robots

mission to mars

Two Houston-area spacetech companies have landed a portion of a $17 million award from NASA to develop robots for exploring the surface of Mars, the agency announced this month.

Houston-based Inuitive Machines and Webster, Texas-based MEI Technologies, which does business as Aegis Aerospace, were among the seven companies selected to receive the funding from NASA's Science Transport and Robotic Innovation for Deployment and Exploration (STRIDE) initiative.

According to the release from NASA, the companies are tasked with creating "innovative mobility systems" that would allow future Mars missions to access more challenging terrain and difficult-to-reach regions of the planet, and to travel farther distances. NASA estimated that the work will begin this fall.

NASA solicited proposals for participants in the STRIDE initiative in January. The seven named companies are the first selected to participate in the program.

The additional five companies to receive STRIDE funding include:

"STRIDE demonstrates NASA’s commitment to strong public-private partnerships, allowing the agency to explore new approaches for Mars surface exploration while identifying key capability gaps and development needs for commercial systems that could operate and traverse realistic Martian environments," NASA shared in the announcement.

Last month, Intuitive Machines was awarded $148.3 million to deliver its Nova-C lander to the moon. The funding was part of $600 million the space agency awarded to three companies as part of its Moon Base Program and was Intuitive Machines' sixth task order under NASA's Commercial Lunar Payload Services (CLPS) program. Astrobotic was also one of the companies to land funding for the Moon Base program, as well as Austin-based Firefly Aerospace.

Around the same time, Firefly Aerospace was awarded a $13 million subcontract from NASA’s Jet Propulsion Laboratory to develop technology for NASA’s SkyFall mission to Mars. The mission aims to deploy three Mars helicopters to "perform science and demonstrate airborne subsurface mapping and resource prospecting on the planet." Read more here.